Generation Bio Co
GBIO·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$4.31
Today
-19.5%
YTD
-24.2%
About
Generation Bio Co. develops programs for rare and prevalent diseases of the retina, liver, the central nervous system, and skeletal muscle. Founded in 2016, Generation Bio operates locally and has its headquarters in Cambridge, Massachusetts. The company's stock is listed using the GBIO ticker on the NASDAQ GS. Add GBIO stock to your eToro watchlist to keep up to date on the latest price changes.
Price chart
Closing price history for GBIO (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-0.57
P/S (TTM)2.36
P/B (TTM)0.71
Market cap$35.98M
Cap tierMicro-cap
Industry avg P/E-7.37
Profitability
Gross margin68.24%
EBIT margin-512.53%
Net margin-346.30%
ROE-80.81%
ROA-33.79%
Earnings & Revenue
Revenue (TTM)$15.27M
Revenue growth (1Y)-17.8%
EPS (TTM)-$9.35
Free cash flow$-114.73M
Total debt$26.10M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)2.00
Employees115
Next earnings12 Mar '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.